1
|
Karahan D, Şahin İ. Evaluation of hepatosteatosis and gallstone disease in patients with chronic kidney disease. Hemodial Int 2024. [PMID: 38558287 DOI: 10.1111/hdi.13151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2023] [Revised: 03/15/2024] [Accepted: 03/20/2024] [Indexed: 04/04/2024]
Abstract
INTRODUCTION The prevalence rates of hepatosteatosis and gallstones are increasing owing to the multifactorial causes of chronic kidney disease, and the prevalence may change with the availability of different forms of renal replacement therapy. We aimed to determine the incidence or prevalence rates of hepatosteatosis, cholelithiasis, and acute cholecystitis in patients with chronic kidney disease and compare them between renal replacement therapy modalities. METHODS A total of 270 patients (90 with chronic kidney disease stages III-V, 90 undergoing peritoneal dialysis, and 90 undergoing hemodialysis) were included and categorized into the pre-dialysis, hemodialysis, and peritoneal dialysis groups. The patients were questioned about previous gallbladder surgeries and chronic diseases. The results of abdominal ultrasonography, tomography, and magnetic resonance imaging were retrospectively evaluated with respect to the findings on the hepatobiliary system. Hepatosteatosis and cholelithiasis were diagnosed by expert radiologists on the basis of abdominal ultrasonography, tomography, and magnetic resonance imaging findings. The prevalence rates of hepatosteatosis, cholelithiasis, and other liver findings were compared between the groups. FINDINGS Hepatosteatosis and cholelithiasis were detected in 16.7% and 21.5% of the 270 cases, respectively. Hepatosteatosis was present in 17.8%, 25.6%, and 6.7% of patients in the pre-dialysis, hemodialysis, and peritoneal dialysis groups, respectively. The prevalence of hepatosteatosis was significantly higher in patients undergoing hemodialysis than in patients undergoing peritoneal dialysis (p = 0.002). However, no statistically significant difference was found between the peritoneal dialysis and pre-dialysis groups or between the hemodialysis and pre-dialysis groups (p >0.05). The prevalence rates of cholelithiasis were 15.6%, 28.9%, and 20.0%, in the pre-dialysis, hemodialysis, and peritoneal dialysis groups, respectively, and there were no statistically significant differences among the groups. The incidence of acute cholecystitis was significantly higher in the hemodialysis group than in the pre-dialysis group (p = 0.006). DISCUSSION Our study showed that the hepatobiliary system is frequently affected in chronic kidney disease and that the findings may differ depending on the renal replacement therapy modality.
Collapse
Affiliation(s)
- Doğu Karahan
- Department of Internal Medicine, Malatya Turgut Özal University School of Medicine, Malatya, Turkey
| | - İdris Şahin
- Department of Nephrology, İnonu University School of Medicine, Malatya, Turkey
| |
Collapse
|
2
|
Çalişkan E, Öztürk CE, Öksüz Ş, Ince N, Yekenkurul D, Kahraman G, Duran P, Şahin İ. Monitoring of antibody levels in healthcare workers after inactivated coronavirus disease 19 vaccination. Rev Assoc Med Bras (1992) 2023; 69:e20220766. [PMID: 38055449 DOI: 10.1590/1806-9282.20220766] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/09/2022] [Accepted: 09/27/2022] [Indexed: 12/08/2023]
Abstract
OBJECTIVE Because of the coronavirus disease 19 pandemic, studies on vaccination are being conducted in our country as well as across the world. In this study, the antibody levels in healthcare workers vaccinated with two doses of inactivated vaccine and the factors affecting these levels were investigated. METHODS Randomly selected volunteers from healthcare workers, who had been vaccinated with two doses of inactivated vaccine in January to February 2021, were included in the study. Blood samples were drawn twice, 1 month and 6 months after the second dose vaccine (CoronaVac:Sinovac Life Science Co, Ltd, Beijing, China). The antibody levels were determined by the chemiluminescence microparticle immunoassay method using kits for quantitative detection of immunoglobulin class G antibodies to severe acute respiratory syndrome coronavirus 2. RESULTS The mean antibody levels of 129 volunteers were 1232.5 (min: 103 to max: 7151) AU/mL in the first month and 403.5 (min: 23 to max: 4963) AU/mL in the sixth month. According to the survey results, 91 (71%) volunteers had not been diagnosed with coronavirus disease 19 before vaccination. The antibody levels 1 month and 6 months after the second dose of vaccination were significantly higher in those who had been diagnosed with coronavirus disease 19 before vaccination than in those who had not. It was found that age, gender, fast food, or healthy nutrition had no effect on antibody levels. CONCLUSION Vaccines are very important both to protect against coronavirus disease 19 and to experience only a mild form of the disease. Immunoglobulin class G levels formed after vaccination may be affected by many factors and may decrease over time.
Collapse
Affiliation(s)
- Emel Çalişkan
- Düzce University, Health Practice and Research Center, Department of Medical Microbiology - Düzce, Turkey
| | - Cihadiye Elif Öztürk
- Arel University, Medical Faculty, Department of Clinical Microbiology and Infection Disease - İstanbul, Turkey
| | - Şükrü Öksüz
- Düzce University, Health Practice and Research Center, Department of Medical Microbiology - Düzce, Turkey
| | - Nevin Ince
- Düzce University, Health Practice and Research Center, Department of Clinical Microbiology and Infection Disease - Düzce, Turkey
| | - Dilek Yekenkurul
- Düzce University, Health Practice and Research Center, Department of Clinical Microbiology and Infection Disease - Düzce, Turkey
| | - Gözde Kahraman
- Düzce University, Health Practice and Research Center, Department of Medical Microbiology - Düzce, Turkey
| | - Pelin Duran
- Düzce University, Health Practice and Research Center, Department of Medical Microbiology - Düzce, Turkey
| | - İdris Şahin
- Düzce University, Health Practice and Research Center, Department of Medical Microbiology - Düzce, Turkey
| |
Collapse
|
3
|
Şahin İ. SYNTHESIS AND CHARACTERIZATION OF SCHIFF BASES CONTAINING 1,2,3-TRIAZOLE UNIT: PHOTOPHYSICAL AND ACETYL CHOLINE (AChE) INHIBITORY PROPERTIES. J STRUCT CHEM+ 2022. [DOI: 10.1134/s0022476622110087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
4
|
Gül CB, Küçük M, Öztürk S, Demir E, Eren N, Şumnu A, Seyahi N, Güllülü M, Dede F, Derici Ü, Koç Y, Şahin G, Oymak O, Sahin GM, Tatar E, Dursun B, Dheir H, Apaydın S, Süleymanlar G, Ulu S, Altınören O, Kutlay S, Meşe M, Şahin İ, Üstündağ S, Türkmen K, Yılmaz ME, Kazancıoğlu RT, Uzun Ö, Candan F, Aydın Z, Oygar D, Aktaş N, Erdem Y, Paydaş S, Taymez D, Can B, Kıykım A, Koç L, Sezer S, Duranay M, Bardak S, Altıntepe L, Kaya B, Azak A, Ecder SA, Çavdar C, Selçuk NY. Trends of primary glomerular disease in Turkey: TSN-GOLD registry report. Int Urol Nephrol 2022; 54:2285-2294. [PMID: 35107695 DOI: 10.1007/s11255-022-03123-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2021] [Accepted: 01/11/2022] [Indexed: 11/28/2022]
Abstract
BACKGROUND Although several renal biopsy registry reports have been published worldwide, there are no data on primary glomerular disease trends in Turkey. METHODS Three thousand eight-hundred fifty-eight native kidney biopsy records were assessed in the Turkish Society of Nephrology Primary Glomerulopathy Working Group (TSN-GOLD) Registry. Secondary disease and transplant biopsies were not recorded in the registry. These records were divided into four periods, before 2009, 2009 to 2013, 2013-2017, and 2017-current. RESULTS A total of 3858 patients (43.6% female, 6.8% elderly) were examined. Nephrotic syndrome was the most common biopsy indication in all periods (58.6%, 53%, 44.1%, 51.6%, respectively). In the whole cohort, IgA nephropathy (IgAN) (25.7%) was the most common PGN with male predominance (62.7%), and IgAN frequency steadily increased through the periods (× 2 = 198, p < 0.001). MGN was the most common nephropathy in the elderly (> 65 years), and there was no trend in this age group. An increasing trend was seen in the frequency of overweight patients (× 2 = 37, p < 0.0001). Although the biopsy rate performed with interventional radiology gradually increased, the mean glomeruli count in the samples did not change over the periods. CONCLUSIONS In Turkey, IgAN is the most common primary glomerulonephritis, and the frequency of this is increasing.
Collapse
Affiliation(s)
- Cuma Bülent Gül
- Department of Nephrology, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.
| | - Mehmet Küçük
- Nephrology, Okmeydanı Training and Research Hospital, Istanbul, Turkey
| | - Savaş Öztürk
- Nephrology, Haseki Training and Resarch Hospital, Istanbul, Turkey
| | - Erol Demir
- Nephrology, Istanbul University Medical School, Istanbul, Turkey
| | - Necmi Eren
- Nephrology, Kocaeli University School of Medicine, Kocaeli, Turkey
| | - Abdullah Şumnu
- Faculty of Medicine, Nephrology, Medipol University Hospital, Istanbul, Turkey
| | - Nurhan Seyahi
- Nephrology, Cerrahpasa University Medical School, Istanbul, Turkey
| | - Mustafa Güllülü
- Nephrology, Uludag University Medical Faculty Hospital, Bursa, Turkey
| | - Fatih Dede
- Nephrology, Ankara Numune Training and Research Hospital, Ankara, Turkey
| | - Ülver Derici
- Nephrology, Gazi University Medical Faculty, Ankara, Turkey
| | - Yener Koç
- Nephrology, Sisli Hamidiye Training and Research Hospital, Istanbul, Turkey
| | - Garip Şahin
- Nephrology, Osmangazi University, Odunpazarı, Eskisehir, Turkey
| | - Oktay Oymak
- Nephrology, Erciyes University, Kayseri, Turkey
| | - Gülizar Manga Sahin
- Nephrology, Sultan Abdülhamid Han Training and Research Hospital, Istanbul, Turkey
| | - Erhan Tatar
- Nephrology, Bozyaka Training and Research Hospital, Izmir, Turkey
| | - Belda Dursun
- Nephrology, Pamukkale University, Denizli, Turkey
| | - Hamad Dheir
- Nephrology, Sakarya Training and Research Hospital, Sakarya, Turkey
| | - Süheyla Apaydın
- Istanbul Sadi Konuk Training and Research Hospital, Istanbul, Turkey
| | | | - Sena Ulu
- Nephrology, Afyon Kocatepe University Medical School, Afyonkarahisar, Turkey
| | - Orçun Altınören
- Nephrology, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey
| | - Sim Kutlay
- Faculty of Medicine, Nephrology, Ankara University, Ankara, Turkey
| | - Meral Meşe
- Nephrology, Istanbul Dr Lufti Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
| | - İdris Şahin
- Nephrology, Inonu University Medical School, Malatya, Turkey
| | - Sedat Üstündağ
- Nephrology, Trakya University Medical School, Edirne, Turkey
| | - Kültigin Türkmen
- Nephrology, Necmettin Erbakan University Meram Medical School, Konya, Turkey
| | | | | | - Özcan Uzun
- Nephrology, Dokuz Eylul University Medical School, Izmir, Turkey
| | - Ferhan Candan
- Nephrology, Cumhuriyet University Medical School, Sivas, Turkey
| | - Zeki Aydın
- Nephrology, Darıca Farabi Training and Research Hospital, Kocaeli, Turkey
| | - Deren Oygar
- Nephrology, Lefkosa Burhan Nalbantoglu Hospital, Lefkosa, Turkish Republic of Northern Cyprus
| | - Nimet Aktaş
- Department of Nephrology, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey
| | - Yunus Erdem
- Nephrology, Hacettepe University Medical School, Ankara, Turkey
| | - Saime Paydaş
- Nephrology, Cukurova University Medical School, Adana, Turkey
| | - Dilek Taymez
- Nephrology, Kocaeli State Hospital, Kocaeli, Turkey
| | - Başak Can
- Nephrology, Okmeydanı Training and Research Hospital, Istanbul, Turkey
| | - Ahmet Kıykım
- Nephrology, Mersin University Medical School, Mersin, Turkey
| | - Leyla Koç
- Nephrology, Taksim Training and Research Hospital, Istanbul, Turkey
| | - Siren Sezer
- Nephrology, Baskent University Medical School, Ankara, Turkey
| | - Murat Duranay
- Nephrology, Ankara Atatürk Training and Research Hospital, Ankara, Turkey
| | - Simge Bardak
- Nephrology, Batman State Hospital, Batman, Turkey
| | | | - Burcu Kaya
- Nephrology, Marmara University Medical School, Istanbul, Turkey
| | - Alper Azak
- Nephrology, Balıkesir Training and Research Hospital, Balikesir, Turkey
| | - Sebahat Alışır Ecder
- Nephrology, Medeniyet University Goztepe Training and Research Hospital, Istanbul, Turkey
| | - Caner Çavdar
- Nephrology, Dokuz Eylul University Medical School, Izmir, Turkey
| | - Nedim Yılmaz Selçuk
- Nephrology, Necmettin Erbakan University Meram Medical School, Konya, Turkey
| |
Collapse
|
5
|
Oto OA, Ozturk S, Arici M, Velioğlu A, Dursun B, Guller N, Şahin İ, Eser ZE, Paydaş S, Trabulus S, Koyuncu S, Uyar M, Ural Z, Sadioğlu RE, Dheir H, Koç NS, Özer H, Durak BA, Gül CB, Kasapoğlu U, Oğuz EG, Tanrısev M, Kuzgun GŞ, Mirioglu S, Dervişoğlu E, Erken E, Görgülü N, Özkurt S, Aydın Z, Kurultak İ, Öğütmen MB, Bakırdöğen S, Kaya B, Karadağ S, Ulu MS, Güngör Ö, Bakır EA, Odabaş AR, Seyahi N, Yıldız A, Ateş K. OUP accepted manuscript. Clin Kidney J 2022; 15:999-1006. [PMID: 35498893 PMCID: PMC8903384 DOI: 10.1093/ckj/sfac045] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2021] [Indexed: 11/23/2022] Open
Abstract
Background In this study, we evaluated 3-month clinical outcomes of kidney transplant recipients (KTR) recovering from COVID-19 and compared them with a control group. Method The primary endpoint was death in the third month. Secondary endpoints were ongoing respiratory symptoms, need for home oxygen therapy, rehospitalization for any reason, lower respiratory tract infection, urinary tract infection, biopsy-proven acute rejection, venous/arterial thromboembolic event, cytomegalovirus (CMV) infection/disease and BK viruria/viremia at 3 months. Results A total of 944 KTR from 29 different centers were included in this study (523 patients in the COVID-19 group; 421 patients in the control group). The mean age was 46 ± 12 years (interquartile range 37–55) and 532 (56.4%) of them were male. Total number of deaths was 8 [7 (1.3%) in COVID-19 group, 1 (0.2%) in control group; P = 0.082]. The proportion of patients with ongoing respiratory symptoms [43 (8.2%) versus 4 (1.0%); P < 0.001] was statistically significantly higher in the COVID-19 group compared with the control group. There was no significant difference between the two groups in terms of other secondary endpoints. Conclusion The prevalence of ongoing respiratory symptoms increased in the first 3 months post-COVID in KTRs who have recovered from COVID-19, but mortality was not significantly different.
Collapse
Affiliation(s)
- Ozgur Akin Oto
- Department of Internal Medicine, Division of Nephrology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey
| | - Savas Ozturk
- Department of Internal Medicine, Division of Nephrology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey
| | | | - Arzu Velioğlu
- Department of Internal Medicine, Division of Nephrology, Marmara University, School of Medicine, Istanbul, Turkey
| | - Belda Dursun
- Department of Internal Medicine, Division of Nephrology, Pamukkale University, Faculty of Medicine, Denizli, Turkey
| | - Nurana Guller
- Department of Internal Medicine, Division of Nephrology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey
| | - İdris Şahin
- Department of Internal Medicine, Nephrology Division, Inonu University, Faculty of Medicine, Malatya, Turkey
| | - Zeynep Ebru Eser
- Department of Internal Medicine, Division of Nephrology, Mersin University, Mersin Faculty of Medicine, Mersin, Turkey
| | - Saime Paydaş
- Department of Internal Medicine, Division of Nephrology, Çukurova University Faculty of Medicine, Adana, Turkey
| | - Sinan Trabulus
- Department of Internal Medicine, Division of Nephrology, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Turkey
| | - Sümeyra Koyuncu
- Department of Internal Medicine, Division of Nephrology, Erciyes University, Erciyes Faculty of Medicine, Kayseri, Turkey
| | - Murathan Uyar
- Department of Internal Medicine, Division of Nephrology, Yeni Yüzyıl University, Gaziosmanpaşa Hospital, Istanbul, Turkey
| | - Zeynep Ural
- Department of İnternal Medicine, Division of Nephrology Gazi University, Faculty of Medicine, Ankara, Turkey
| | | | - Hamad Dheir
- Department of Internal Medicine, Division of Nephrology, Sakarya University Training and Research Hospital, Sakarya, Turkey
| | - Neriman Sıla Koç
- Department of Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey
| | - Hakan Özer
- Division of Nephrology, Konya Necmettin Erbakan University, Meram Faculty of Medicine, Konya, Turkey
| | - Beyza Algül Durak
- Department of Nephrology, Ankara Bilkent City Hospital, Ankara, Turkey
| | - Cuma Bülent Gül
- Department of Nephrology, University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Istanbul, Turkey
| | - Umut Kasapoğlu
- Department of Nephrology, University of Health Sciences, Bakirkoy Dr Sadi Konuk Training and Research Hospital, Istanbul, Turkey
| | - Ebru Gök Oğuz
- Department of Nephrology, University of Health Sciences, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey
| | - Mehmet Tanrısev
- Department of Nephrology, University of Health Sciences, Izmir Faculty of Medicine, Tepecik Training and Research Hospital, Izmir, Turkey
| | - Gülşah Şaşak Kuzgun
- Department of Nephrology, Goztepe Prof Dr Suleyman Yalcin City Hospital, Istanbul, Turkey
| | - Safak Mirioglu
- Division of Nephrology, Department of Internal Medicine, Bezmialem Vakif University School of Medicine, Istanbul, Turkey
| | - Erkan Dervişoğlu
- Department of Internal Medicine, Division of Nephrology, Kocaeli University, Faculty of Medicine, Kocaeli, Turkey
| | - Ertuğrul Erken
- Department of Nephrology, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey
| | - Numan Görgülü
- Department of Nephrology, University of Health Sciences, Bagcilar Training and Research Hospital, Istanbul, Turkey
| | - Sultan Özkurt
- Department of Internal Medicine, Division of Nephrology, Eskişehir Osmangazi University, Faculty of Medicine, Eskişehir, Turkey
| | - Zeki Aydın
- Department of Nephrology, University of Health Sciences, Darıca Farabi Training and Research Hospital, Darica, Turkey
| | - İlhan Kurultak
- Department of Internal Medicine, Division of Nephrology, Trakya University, Faculty of Medicine, Edirne, Turkey
| | - Melike Betül Öğütmen
- Department of Nephrology, University of Health Sciences, Haydarpaşa Numune Training and Research Hospital, Istanbul, Turkey
| | - Serkan Bakırdöğen
- Department of Internal Medicine, Division of Nephrology, Canakkale Onsekiz Mart University, School of Medicine, Canakkale, Turkey
| | - Burcu Kaya
- Department of Internal Medicine, Division of Nephrology, Marmara University, School of Medicine, Istanbul, Turkey
| | - Serhat Karadağ
- Department of Nephrology, University of Health Sciences, Haseki Training and Research Hospital, Istanbul, Turkey
| | - Memnune Sena Ulu
- Department of Internal Medicine, Division of Nephrology, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey
| | - Özkan Güngör
- Department of Nephrology, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey
| | - Elif Arı Bakır
- Department of Internal Medicine, Division of Nephrology University of Health Sciences, Kartal Training Hospital, Istanbul, Turkey
| | - Ali Rıza Odabaş
- Department of Nephrology, University of Health Sciences, Sultan 2. Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
| | - Nurhan Seyahi
- Department of Internal Medicine, Division of Nephrology, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Turkey
| | - Alaattin Yıldız
- Department of Internal Medicine, Division of Nephrology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey
| | - Kenan Ateş
- Department of Nephrology, Ankara University School of Medicine, Ankara, Turkey
| |
Collapse
|
6
|
Öztürk S, Turgutalp K, Arıcı M, Çetinkaya H, Altıparmak MR, Aydın Z, Soypaçacı Z, Bora F, Kara E, Cebeci E, Özler TE, Dölarslan ME, Sipahi S, Ayar Y, Şahin İ, Bakırdöğen S, İslam M, Görgülü N, Öğütmen MB, Şengül E, Güngör Ö, Seyahi N, Tokgöz BÜ, Odabaş AR, Tonbul HZ, Sezer S, Yıldız A, Ateş K. Impact of hospital-acquired acute kidney injury on Covid-19 outcomes in patients with and without chronic kidney disease: a multicenter retrospective cohort study. Turk J Med Sci 2021; 51:947-961. [PMID: 33611868 PMCID: PMC8283512 DOI: 10.3906/sag-2011-169] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2020] [Accepted: 02/21/2021] [Indexed: 01/08/2023] Open
Abstract
Background/aim Hospital-acquired acute kidney injury (HA-AKI) may commonly develop in Covid-19 patients and is expected to have higher mortality. There is little comparative data investigating the effect of HA-AKI on mortality of chronic kidney disease (CKD) patients and a control group of general population suffering from Covid-19. Materials and methods HA-AKI development was assessed in a group of stage 3–5 CKD patients and control group without CKD among adult patients hospitalized for Covid-19. The role of AKI development on the outcome (in-hospital mortality and admission to the intensive care unit [ICU]) of patients with and without CKD was compared. Results Among 621 hospitalized patients (age 60 [IQR: 47–73]), women: 44.1%), AKI developed in 32.5% of the patients, as stage 1 in 84.2%, stage 2 in 8.4%, and stage 3 in 7.4%. AKI developed in 48.0 % of CKD patients, whereas it developed in 17.6% of patients without CKD. CKD patients with HA-AKI had the highest mortality rate of 41.1% compared to 14.3% of patients with HA-AKI but no CKD (p < 0.001). However, patients with AKI+non-CKD had similar rates of ICU admission, mechanical ventilation, and death rate to patients with CKD without AKI. Adjusted mortality risks of the AKI+non-CKD group (HR: 9.0, 95% CI: 1.9–44.2) and AKI+CKD group (HR: 7.9, 95% CI: 1.9–33.3) were significantly higher than that of the non-AKI+non-CKD group. Conclusion AKI frequently develops in hospitalized patients due to Covid-19 and is associated with high mortality. HA-AKI has worse outcomes whether it develops in patients with or without CKD, but the worst outcome was seen in AKI+CKD patients.
Collapse
Affiliation(s)
- Savaş Öztürk
- Department of Nephrology, University of Health Sciences, Haseki Training and Research Hospital, İstanbul, Turkey
| | - Kenan Turgutalp
- Department of Internal Medicine, Division of Nephrology, Mersin University Faculty of Medicine, Training and Research Hospital, Mersin, Turkey
| | - Mustafa Arıcı
- Department of Nephrology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
| | - Hakkı Çetinkaya
- Department of Nephrology, Sultan 2. Abdulhamid Han Training and Research Hospital, University of Health Sciences, İstanbul, Turkey
| | - Mehmet Rıza Altıparmak
- Department of Internal Medicine, Division of Nephrology, Cerrahpaşa Faculty of Medicine, İstanbul University–Cerrahpaşa, İstanbul, Turkey
| | - Zeki Aydın
- Department of Nephrology, Darıca Farabi Training and Research Hospital, Kocaeli, Turkey
| | - Zeki Soypaçacı
- Department of Internal Medicine, Division of Nephrology, İzmir Katip Çelebi University, Atatürk Training and Research Hospital, İzmir, Turkey
| | - Feyza Bora
- Department of Internal Medicine, Division of Nephrology, Faculty of Medicine, Akdeniz University, Antalya, Turkey
| | - Ekrem Kara
- Department of Internal Medicine, Division of Nephrology, Faculty of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey
| | - Egemen Cebeci
- Department of Nephrology, University of Health Sciences, Haseki Training and Research Hospital, İstanbul, Turkey
| | - Tuba Elif Özler
- Department of Internal Medicine, Division of Nephrology, Kanuni Sultan Süleyman Training and Research Hospital, University of Health Sciences, İstanbul, Turkey
| | - Mürşide Esra Dölarslan
- Department of Nephrology, Trabzon Kanuni Training and Research Hospital, University of Health Sciences, Trabzon, Turkey
| | - Savaş Sipahi
- Department of Internal Medicine, Division of Nephrology, Sakarya University Training and Research Hospital, Sakarya, Turkey
| | - Yavuz Ayar
- Department of Nephrology, Bursa City Hospital, Bursa, Turkey
| | - İdris Şahin
- Department of Internal Medicine, Division of Nephrology, Turgut Özal Medical Center, İnönü University Faculty of Medicine, Malatya, Turkey
| | - Serkan Bakırdöğen
- Department of Internal Medicine, Division of Nephrology, Çanakkale Onsekiz Mart University, Çanakkale, Turkey
| | - Mahmud İslam
- Department of Nephrology, Zonguldak Atatürk State Hospital, Zonguldak, Turkey
| | - Numan Görgülü
- Department of Internal Medicine, Division of Nephrology, Bağcılar Training and Research Hospital, University of Health Sciences, İstanbul, Turkey
| | - Melike Betül Öğütmen
- Department of Nephrology, Haydarpaşa Numune Training and Research Hospital, University of Health Sciences, İstanbul, Turkey
| | - Erkan Şengül
- Department of Nephrology, Kocaeli Derince Training and Research Hospital, University of Health Sciences, Kocaeli, Turkey
| | - Özkan Güngör
- Department of Nephrology, Faculty of Medicine, Kahramanmaraş Sütçü İmam University, Kahramanmaraş, Turkey
| | - Nurhan Seyahi
- Department of Internal Medicine, Division of Nephrology, Cerrahpaşa Faculty of Medicine, İstanbul University–Cerrahpaşa, İstanbul, Turkey
| | - BÜlent Tokgöz
- Department of Nephrology, Faculty of Medicine, Erciyes University, Kayseri, Turkey
| | - Ali Rıza Odabaş
- Department of Nephrology, Sultan 2. Abdulhamid Han Training and Research Hospital, University of Health Sciences, İstanbul, Turkey
| | - Halil Zeki Tonbul
- Department of Nephrology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey
| | - Siren Sezer
- Department of Internal Medicine, Division of Nephrology, Faculty of Medicine, Atılım University, Ankara, Turkey
| | - Alaattin Yıldız
- Department of Internal Medicine, Division of Nephrology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey
| | - Kenan Ateş
- Department of Internal Medicine, Division of Nephrology, Faculty of Medicine, Ankara University, Ankara, Turkey
| |
Collapse
|
7
|
Topaloğlu Ö, Çimci M, Yoloğlu S, Şahin İ. Is there association between QRS-T angle, and hormonal and sonographic features in polycystic ovarian syndrome? Eur Rev Med Pharmacol Sci 2020; 24:7372-7380. [PMID: 32706076 DOI: 10.26355/eurrev_202007_21905] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE Polycystic ovary syndrome (PCOS) is a complex disorder comprising ovulatory dysfunction, hyperandrogenism, and polycystic ovaries (PCO). Several studies have used electrocardiography (ECG) to assess PCOS patients. We aimed to analyze the associations among QRS-T angle, hormonal parameters, and ovarian and thyroid sonography in PCOS. PATIENTS AND METHODS Adult females with PCOS, but without comorbid illness, were included in our study. Demographic and clinical features (body mass index, Ferriman-Gallwey score, phenotype) were analyzed, as well as laboratory test results. Based on standard 12-lead ECGs, frontal plane QRS-T angles were calculated, defined as the angle between the mean QRS and the mean T vector, and verified with automatic instrument measurements. Values within the range -46 to +59° were classified as "normal", and those out of this range as "abnormal". Patients were divided into groups according to the presence of thyroid nodules, echogenicity (normal/decreased), and vascularity (normal/increased) based on thyroid sonography, and by mean ovarian volume (MOV ≥ 10/< 10 mL) or apparent PCO based on ovarian sonography. RESULTS The mean age of the 92 patients was 22.68 ± 4.58 years; 11 patients (11.9%) had abnormal QRS-T angles. Demographic, clinical, electrocardiographic, and laboratory parameters were similar between the normal and abnormal QRS-T angle groups, with the exception of MOV, which was higher in the latter group (p=0.032). Among all clinical and laboratory parameters, only MOV was a strong predictor of abnormal QRS-T angle (p=0.016). CONCLUSIONS Our study is the first to analyze the association between the QRS-T angle and hormonal and sonographic features of patients with PCOS. A small percentage of patients had abnormal QRS-T angles, and a large MOV was a strong predictor of this abnormality.
Collapse
Affiliation(s)
- Ö Topaloğlu
- University of Health Sciences, Kocaeli Training and Research Hospital, Endocrinology Clinics, Kocaeli, Turkey.
| | | | | | | |
Collapse
|
8
|
AVCIOĞLU F, Öztürk CE, Şahin İ, Öksüz Ş, Kızılırmak A, Akar N. Metisiline Dirençli Stafilokoklarda Azalmış Vankomisin Duyarlılığının Araştırılması. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 2020. [DOI: 10.33631/duzcesbed.578228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
9
|
Küçüktaş P, Şahin İ, Çalışkan E, Kılınçel Ö. Düzce Üniversitesi Sağlık Uygulama Ve Araştırma Merkezi’nde Kan Ve Kan Bileşenlerinin Kliniklere Göre Kullanımlarının Değerlendirilmesi. Kocaeli Üniversitesi Sağlık Bilimleri Dergisi 2019. [DOI: 10.30934/kusbed.460700] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
10
|
Kılınçel Ö, Çalışkan E, Şahin İ, Öztürk CE, Kılıç N, Öksüz Ş. The effect of melatonin on antifungal susceptibility in planktonic and biofilm forms ofCandidastrains isolated from clinical samples. Med Mycol 2018; 57:45-51. [DOI: 10.1093/mmy/myx157] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2017] [Accepted: 11/30/2017] [Indexed: 11/13/2022] Open
Affiliation(s)
- Özge Kılınçel
- Düzce Atatürk State Hospital, Medical Microbiology, Düzce, Turkey
| | - Emel Çalışkan
- Düzce University Faculty of Medicine, Medical Microbiology, Düzce, Turkey
| | - İdris Şahin
- Düzce University Faculty of Medicine, Medical Microbiology, Düzce, Turkey
| | | | - Nida Kılıç
- Ankara Atatürk Chest Diseases and Thoracic Surgery Training and Research Hospital, Medical Microbiology, Ankara, TURKEY
| | - Şükrü Öksüz
- Düzce University Faculty of Medicine, Medical Microbiology, Düzce, Turkey
| |
Collapse
|
11
|
Öztürk CE, Şahin İ, Öksüz Ş, Kılıç N, Kılınçel Ö, Aydın L, Atik D, Afşin E. [Investigation of Mycobacterium bovis subsp. bovis among the strains of Mycobacterium tuberculosis complex isolated in Düzce Province, Turkey]. MIKROBIYOL BUL 2016; 50:392-400. [PMID: 27525395 DOI: 10.5578/mb.27784] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Throughout the history of mankind, tuberculosis (TB) has caused serious illness and still continues to do so. Archaeobiological studies indicated that TB in humans dates back to 4000-8000 BC, and cases were shown to be due to Mycobacterium bovis subsp.bovis rather than Mycobacterium tuberculosis. Moreover, this situation was thought to begin with domestication of animals, consumption of their milk, and living together in the same environment with them. Over time, with the consumption of boiled milk and with the establishment of separate animal shelters, M.bovis subsp. bovis infection began to be seen rarely. Today, M.bovis infection is mostly transmitted from animals to humans and very rarely from humans to other humans. The most significant means of transmission of the infection are to the gastrointestinal tract via consumption of raw milk and to the respiratory system via droplet infection from the animals with disease. In this study, it was planned to investigate the cause of occurrence of TB in cattles in Düzce in the past few years along with the presence of bovine type TB in cases of human tuberculosis. We aimed to carry out subtype determination of the M.tuberculosis complex (MTBC) strains isolated in our mycobacteriology laboratory between the years 2004-2014, and evaluate the clinical and sociodemographic data of patients in whom M.bovis subsp. bovis was detected. The strains that were selected for the study have been isolated from radiometric BACTEC™ 12B broth and/or Löwenstein-Jensen (LJ) media between 2004-2009, and BACTEC™ MGIT™ (Mycobacteria Growth Indicator Tube) and/or LJ media between 2009-2014 periods. The GenoType MTBC Kit (Hain-Lifescience GmbH, Germany) was used in the study for determination of the subspecies. Extraction and amplification of DNA and hybridizations were performed according to test procedure in order to investigate the presence of subtypes of the MTBC species in skimmed milk from collections stored at -20°C. In the study, MTBC strains isolated from 220 patients (217 adults, 3 children; 145 male, 75 female) were evaluated and 217 (98.6%) of them were identified as M.tuberculosis/M.canettii and three (1.4%) as M.bovis subsp. bovis. When the distribution of the isolates were evaluated according to the years, it was noted that three (2.8%) cases out of 106 patients within the last three years, were found to be infected with M.bovis subsp. bovis, while none were detected in the 114 cases from the previous years. This data emphasized a parallel course with the reported cases of cattle tuberculosis in recent years. The risk factors, clinical and sociodemographic features, treatment process, outcomes, and mycobacteriological findings of those three patients were reviewed. Accordingly, the first case was a 63-year-old female with diabetes mellitus and chronic renal failure, who was dealing with animal husbandry. She was diagnosed as miliary TB on July 2012 and completed her treatment schedule. The second case, who was also dealing with animal husbandry was a 85-year-old male with prostate carcinoma. This case was diagnosed as pulmonary TB on December 2013, however he has quited the treatment and died two months later. The third case, a 27-year-old female was admitted to the hospital with a cervical mass that developed when she was working as a seasonal laborer. She was diagnosed to have lymph node TB in September 2014 and completed her treatment schedule. The strains isolated from the first and third cases were found to be susceptible to streptomycin (STR), isoniazid (INH), rifampicin (RIF) and ethambutol (EMB), while the strain isolated from the second case was susceptible to STR, INH and RIF, but resistant to EMB. All of the three isolates were resistant to pyrazinamide. As a result, it was concluded that large-scaled and attentive monitoring of TB infections in animals, as well as searching for M.bovis subsp. bovis in TB cases, especially in high-risk groups would be essential for an accurate diagnosis.
Collapse
Affiliation(s)
- Cihadiye Elif Öztürk
- Düzce University Faculty of Medicine, Department of Medical Microbiology, Düzce, Turkey.
| | | | | | | | | | | | | | | |
Collapse
|
12
|
Karabulut A, Şahin İ, Avcı İ, Doğan Z, Uzunlar B, Satılmış S. OP-338 Impact of Serum Alkaline Phosphatase Level on the Coronary Collateral Circulation. Am J Cardiol 2014. [DOI: 10.1016/j.amjcard.2014.01.210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
13
|
Elalmış ÖU, Gürsoy H, Kanat S, Şahin D, Şahin İ, İleri M. OP-322 Four Cases of Hypereosinophilic Syndrome with Different Cardiac Presentations. Am J Cardiol 2014. [DOI: 10.1016/j.amjcard.2014.01.192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
14
|
|
15
|
Kocaman S, Erdogan T, Durakoglugil M, Çetin M, Uğurlu Y, Şahin İ, Çanga A. OP-098 PREMATURE HAIR WHITENING IS AN INDEPENDENT PREDICTOR OF CAROTID INTIMA-MEDIA THICKNESS IN YOUNG AND MIDDLE-AGED MEN. Int J Cardiol 2013. [DOI: 10.1016/s0167-5273(13)70099-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
16
|
|